A medical device for Cystic Fibrosis (CF) sufferers which lessens their exposure to infections resulting in fewer doctors’ visits, reduced antibiotic usage and shorter hospital stays, is expected to be market ready within two years.

Researchers working on a wearable-robotics project, aimed at improving movement for people with reduced mobility, plan to build the first fully-functional prototype of XoSoft ‘intelligent’ trousers by 2019.